Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

Interpersonal rejection results in increased appearance satisfaction for women who rely on body weight for self-worth.

O'Driscoll LM, Jarry JL.

Body Image. 2014 Oct 21;12C:36-43. doi: 10.1016/j.bodyim.2014.09.003. [Epub ahead of print]

PMID:
25462880
[PubMed - as supplied by publisher]
2.

Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies.

O'Neill S, O'Driscoll L.

Obes Rev. 2015 Jan;16(1):1-12. doi: 10.1111/obr.12229. Epub 2014 Nov 18.

PMID:
25407540
[PubMed - in process]
3.

Receptor tyrosine kinases and drug resistance: development and characterization of in vitro models of resistance to RTK inhibitors.

Corcoran C, O'Driscoll L.

Methods Mol Biol. 2015;1233:169-80. doi: 10.1007/978-1-4939-1789-1_16.

PMID:
25319899
[PubMed - in process]
4.

Receptor tyrosine kinase targeting in multicellular spheroids.

Breslin S, O'Driscoll L.

Methods Mol Biol. 2015;1233:161-8. doi: 10.1007/978-1-4939-1789-1_15.

PMID:
25319898
[PubMed - in process]
5.

Analysis of changes in phosphorylation of receptor tyrosine kinases: antibody arrays.

Rani S, O'Driscoll L.

Methods Mol Biol. 2015;1233:15-23. doi: 10.1007/978-1-4939-1789-1_2.

PMID:
25319885
[PubMed - in process]
6.

miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.

Corcoran C, Rani S, O'Driscoll L.

Prostate. 2014 Sep;74(13):1320-34. doi: 10.1002/pros.22848. Epub 2014 Jul 22.

PMID:
25053345
[PubMed - indexed for MEDLINE]
7.

Neuromedin U: a candidate biomarker and therapeutic target to predict and overcome resistance to HER-tyrosine kinase inhibitors.

Rani S, Corcoran C, Shiels L, Germano S, Breslin S, Madden S, McDermott MS, Browne BC, O'Donovan N, Crown J, Gogarty M, Byrne AT, O'Driscoll L.

Cancer Res. 2014 Jul 15;74(14):3821-33. doi: 10.1158/0008-5472.CAN-13-2053. Epub 2014 May 29.

PMID:
24876102
[PubMed - indexed for MEDLINE]
8.

miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer.

Corcoran C, Rani S, Breslin S, Gogarty M, Ghobrial IM, Crown J, O'Driscoll L.

Mol Cancer. 2014 Mar 24;13:71. doi: 10.1186/1476-4598-13-71.

PMID:
24655723
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Exosomes are involved in mediating radiation induced bystander signaling in human keratinocyte cells.

Jella KK, Rani S, O'Driscoll L, McClean B, Byrne HJ, Lyng FM.

Radiat Res. 2014 Feb;181(2):138-45. doi: 10.1667/RR13337.1. Epub 2014 Feb 6.

PMID:
24502353
[PubMed - indexed for MEDLINE]
10.

Lori O'Driscoll founder of the Dravet Syndrome Foundation.

Meskis MA, O'Driscoll L, Renz A.

Epilepsia. 2014 Feb;55(2):201-2. doi: 10.1111/epi.12496. Epub 2014 Jan 13. No abstract available.

PMID:
24417630
[PubMed - indexed for MEDLINE]
11.

ISEV position paper: extracellular vesicle RNA analysis and bioinformatics.

Hill AF, Pegtel DM, Lambertz U, Leonardi T, O'Driscoll L, Pluchino S, Ter-Ovanesyan D, Nolte-'t Hoen EN.

J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22859. eCollection 2013.

PMID:
24376909
[PubMed]
Free PMC Article
12.

Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinoma.

Rani S, Gately K, Crown J, O'Byrne K, O'Driscoll L.

Cancer Biol Ther. 2013 Dec;14(12):1104-12. doi: 10.4161/cbt.26370. Epub 2013 Sep 4.

PMID:
24025412
[PubMed - in process]
Free PMC Article
13.

Comparative antiproliferative effects of iniparib and olaparib on a panel of triple-negative and non-triple-negative breast cancer cell lines.

Pierce A, McGowan PM, Cotter M, Mullooly M, O'Donovan N, Rani S, O'Driscoll L, Crown J, Duffy MJ.

Cancer Biol Ther. 2013 Jun;14(6):537-45. doi: 10.4161/cbt.24349.

PMID:
23760496
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis.

Clarke C, Madden SF, Doolan P, Aherne ST, Joyce H, O'Driscoll L, Gallagher WM, Hennessy BT, Moriarty M, Crown J, Kennedy S, Clynes M.

Carcinogenesis. 2013 Oct;34(10):2300-8. doi: 10.1093/carcin/bgt208. Epub 2013 Jun 5.

PMID:
23740839
[PubMed - indexed for MEDLINE]
Free Article
15.

Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells.

O'Brien K, Rani S, Corcoran C, Wallace R, Hughes L, Friel AM, McDonnell S, Crown J, Radomski MW, O'Driscoll L.

Eur J Cancer. 2013 May;49(8):1845-59. doi: 10.1016/j.ejca.2013.01.017. Epub 2013 Feb 27.

PMID:
23453937
[PubMed - indexed for MEDLINE]
16.

Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes.

Corcoran C, Rani S, O'Brien K, O'Neill A, Prencipe M, Sheikh R, Webb G, McDermott R, Watson W, Crown J, O'Driscoll L.

PLoS One. 2012;7(12):e50999. doi: 10.1371/journal.pone.0050999. Epub 2012 Dec 10.

PMID:
23251413
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

EGFR and HER2 inhibition in pancreatic cancer.

Walsh N, Kennedy S, Larkin A, Corkery B, O'Driscoll L, Clynes M, Crown J, O'Donovan N.

Invest New Drugs. 2013 Jun;31(3):558-66. doi: 10.1007/s10637-012-9891-x. Epub 2012 Oct 18.

PMID:
23076814
[PubMed - indexed for MEDLINE]
18.

Three-dimensional cell culture: the missing link in drug discovery.

Breslin S, O'Driscoll L.

Drug Discov Today. 2013 Mar;18(5-6):240-9. doi: 10.1016/j.drudis.2012.10.003. Epub 2012 Oct 13. Review.

PMID:
23073387
[PubMed - indexed for MEDLINE]
19.

The use of LC-MS to identify differentially expressed proteins in docetaxel-resistant prostate cancer cell lines.

O'Connell K, Prencipe M, O'Neill A, Corcoran C, Rani S, Henry M, Dowling P, Meleady P, O'Driscoll L, Watson W, O'Connor R.

Proteomics. 2012 Jul;12(13):2115-26. doi: 10.1002/pmic.201100489.

PMID:
22623417
[PubMed - indexed for MEDLINE]
20.

Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance.

Radziwon-Balicka A, Medina C, O'Driscoll L, Treumann A, Bazou D, Inkielewicz-Stepniak I, Radomski A, Jow H, Radomski MW.

Br J Pharmacol. 2012 Oct;167(4):787-804. doi: 10.1111/j.1476-5381.2012.01991.x.

PMID:
22506717
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk